Biliary atresia (BA) is the leading cause of liver cirrhosis and chronic liver insufficiency in children in the world. Gastroesophageal varices bleeding is an ominous complication of cirrhosis in BA patients and is associated with high morbidity and mortality. In this study, we aimed to investigate the utility of noninvasive Baveno VI and Baveno VII criteria for the screening of varices need treatment (VNT) and the need for liver transplantation in BA patients.

Methods

This study enrolled 48 BA patients (23 females and 25 males) who underwent an esophagogastroduodenoscopy (EGD) and transient elastography at a mean age of 11.18 ± 1.48 years; the clinical data were surveyed in a retrospective design.

Results

The sensitivity and negative predictive value of Baveno VI and Baveno VII criteria for the prediction of VNT in BA patients are both 100% and 100%, respectively. The VNT missing rate of Baveno VI and Baveno VII criteria are both 0% in our cohort. The Baveno VI, expanded Baveno VI, and Baveno VII criteria are also predictive of the need for liver transplantation in our cohort (OR = 10.33, 4.24, and 21.33; p = 0.009, 0.03, and 0.007, respectively).

Conclusion

The Baveno VI and Baveno VII criteria are useful for the screening of VNT and minimize non-necessary invasive EGD in BA patients with low VNT missing rates. The Baveno VI, expanded Baveno VI, and Baveno VII criteria are associated with the need for liver transplantation.

Graphical Abstract

Non-invasive Baveno criteria for BA patients

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

Open Research

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

1Tomita H, Shimojima N, Sasaki H, et al. Predicting cirrhosis and poor outcomes of bile drainage surgery for biliary atresia: a multicentric observational study in Japan. Ann Surg. 2024; 279(4): 692-698.
10.1097/SLA.0000000000006075
PubMed Google Scholar
2Wu JF, Lee CS, Lin WH, et al. Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy. Hepatology. 2018; 68(2): 616-624.
10.1002/hep.29856
PubMed Web of Science® Google Scholar
3Schreiber RA, Barker CC, Roberts EA, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007; 151(6): 659-665.e1.
10.1016/j.jpeds.2007.05.051
PubMed Web of Science® Google Scholar
4Wu JF, Kao PC, Chen HL, et al. A high serum interleukin-12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia. Liver Int. 2012; 32(10): 1557-1563.
10.1111/liv.12001
CAS PubMed Web of Science® Google Scholar
5Hellen DJ, Bennett A, Malla S, et al. Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy. Hepatology. 2023; 77(4): 1274-1286.
10.1097/HEP.0000000000000029
PubMed Web of Science® Google Scholar
6Lim YZ, Zhu M, Wang Y, et al. Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells. J Hepatol. 2024; S0168-8278(24):00151-X. doi:10.1016/j.jhep.2024.02.031
Google Scholar
7Shneider BL, Magee JC, Karpen SJ, et al. Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J Pediatr. 2016; 170: 211-217.e2.
10.1016/j.jpeds.2015.11.058
CAS PubMed Web of Science® Google Scholar
8Huang CY, Chang MH, Chen HL, Ni YH, Hsu HY, Wu JF. Bilirubin level 1 week after hepatoportoenterostomy predicts native liver survival in biliary atresia. Pediatr Res. 2020; 87(4): 730-734.
10.1038/s41390-019-0610-6
CAS PubMed Web of Science® Google Scholar
9Mattos ÂZ, Mattos AA, Daros LF, Musskopf MI. Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices. Ann Hepatol. 2013; 12(5): 810-814.
10.1016/S1665-2681(19)31324-9
PubMed Web of Science® Google Scholar
10Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018; 69(4): 878-885.
10.1016/j.jhep.2018.05.019
PubMed Web of Science® Google Scholar
11Nawalerspanya S, Sripongpun P, Chamroonkul N, Kongkamol C, Piratvisuth T. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies. Ann Hepatol. 2020; 19(2): 209-213.
10.1016/j.aohep.2019.08.005
PubMed Web of Science® Google Scholar
12Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010; 53(4): 630-638.
10.1016/j.jhep.2010.04.019
PubMed Web of Science® Google Scholar
13Kraja B, Mone I, Akshija I, Koçollari A, Prifti S, Burazeri G. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017; 23(26): 4806-4814.
10.3748/wjg.v23.i26.4806
PubMed Web of Science® Google Scholar
14Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017; 66(6): 1980-1988.
10.1002/hep.29363
PubMed Web of Science® Google Scholar
15Tosetti G, Primignani M, La Mura V, et al. Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease. Dig Liver Dis. 2019; 51(8): 1135-1140.
10.1016/j.dld.2018.12.025
PubMed Google Scholar
16Stafylidou M, Paschos P, Katsoula A, et al. Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019; 17(9): 1744-1755.e11.
10.1016/j.cgh.2019.04.062
PubMed Web of Science® Google Scholar
17Kang Y, Park S, Kim S, Han SJ, Koh H. Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix. Clin Res Hepatol Gastroenterol. 2021; 45(1):101437.
10.1016/j.clinre.2020.04.007
PubMed Web of Science® Google Scholar
18de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII: renewing consensus in portal hypertension. J Hepatol. 2022; 76(4): 959-974.
10.1016/j.jhep.2021.12.022
PubMed Web of Science® Google Scholar
19Shi Y, Jiang YZ, Zhou GP, et al. Prognostic factors related to in-hospital death in children with biliary atresia: analysis of a nationwide inpatient database. J Clin Transl Hepatol. 2023; 11(2): 416-424.
PubMed Web of Science® Google Scholar
20Wong YJ, Zhaojin C, Tosetti G, et al. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin Mol Hepatol. 2023; 29(1): 135-145.
10.3350/cmh.2022.0181
PubMed Web of Science® Google Scholar
21Jachs M, Sandmann L, Hartl L, et al. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. J Hepatol. 2024; S0168-8278(24):00156-9. doi:10.1016/j.jhep.2024.03.005
Google Scholar
22Jain V, Burford C, Alexander EC, et al. Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J Hepatol. 2019; 71(1): 71-77.
10.1016/j.jhep.2019.03.005
CAS PubMed Web of Science® Google Scholar
23Kumagi T, Drenth JPH, Guttman O, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int. 2012; 32(3): 510-518.
10.1111/j.1478-3231.2011.02668.x
CAS PubMed Web of Science® Google Scholar
24Lykavieris P, Chardot C, Sokhn M, Gauthier F, Valayer J, Bernard O. Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology. 2005; 41(2): 366-371.
10.1002/hep.20547
CAS PubMed Web of Science® Google Scholar

Volume79, Issue2

August 2024

Pages 222-228